Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
$25.00
Provider: New Constructs, LLC
$25.00
Provider: MacroRisk Analytics/EconomicInvestor
$25.00
Provider: ValuEngine, Inc.
$25.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Celgene Corp announces expansive multi-year strategic alliance with FORMA Therapeutics


Tuesday, 1 Apr 2014 07:30am EDT 

FORMA Therapeutics:Says a second strategic collaboration and option agreement with Celgene Corp.New collaboration will enable FORMA to extend its capabilities across broad areas of chemistry and biology.FORMA received an upfront cash payment of $225 million, and the parties entered into a collaboration with a term of 3 ½ years. 

Company Quote

86.19
-2.93 -3.29%
24 Jul 2014